Background The coronavirus disease 2019 (COVID-19) causes a wide spectrum of lung
manifestations ranging from mild asymptomatic disease to severe respiratory failure. We …

Background Monocytes and macrophages play a pivotal role in inflammation during acute
SARS-CoV-2 infection. However, their contribution to the development of post-acute …

New Findings What is the central question of this study? Are chronotropic responses to a 6‐
minute walk test different in women with post‐acute coronavirus disease 2019 (COVID‐19) …

Background Descriptions of clinical characteristics of patients hospitalised withCOVID-19,
their clinical course and short-term inpatient and outpatient outcomes in deprived urban …

Introduction At the end of the first year of the COVID-19 pandemic, more than 78 million
known survivors were recorded. The long-term pulmonary sequelae of COVID-19 remain …

Introduction Most post COVID-19 follow-up studies are limited to a follow-up of 3 months.
Whether a favorable evolution in lung function and/or radiological abnormalities is to be …

Background Approximately half of COVID-19 survivors present persisting breathlessness,
which may include development of pulmonary fibrosis. Research Question What is the …

Background A comprehensive study of the post-COVID syndrome (PCS) remains scarce in
low-and middle-income countries. We assessed the prevalence, incidence rate, evolution …

Background The usefulness of bronchodilators in coronavirus diseases 2019 (COVID-19)
survivors is still uncertain, especially for patients with a concomitant obstructive lung …

Critically ill COVID-19 patients have to undergo positive pressure ventilation, a non-
physiological and invasive intervention that can be lifesaving in severe ARDS. Similar to any …